Psoriatic Arthritis Therapeutics - Pipeline Review, H2 2015 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/x4p9xn/psoriatic) has announced the addition of the "Psoriatic Arthritis - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Psoriatic Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Psoriatic Arthritis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Psoriatic Arthritis Overview
  3. Therapeutics Development
  4. Pipeline Products for Psoriatic Arthritis - Overview
  5. Pipeline Products for Psoriatic Arthritis - Comparative Analysis
  6. Psoriatic Arthritis - Therapeutics under Development by Companies
  7. Psoriatic Arthritis - Therapeutics under Investigation by Universities/Institutes
  8. Psoriatic Arthritis - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Psoriatic Arthritis - Products under Development by Companies
  13. Psoriatic Arthritis - Products under Investigation by Universities/Institutes
  14. Psoriatic Arthritis - Companies Involved in Therapeutics Development
  • AbbVie Inc.
  • AbGenomics International, Inc.
  • Alder Biopharmaceuticals Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Avesthagen Limited
  • Berg LLC
  • BIOCAD
  • Biocon Limited
  • Bionovis SA
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Celltrion, Inc.
  • Coherus BioSciences, Inc.
  • Eli Lilly and Company
  • Epirus Biopharmaceuticals, Inc.
  • Forward Pharma A/S
  • Genor BioPharma Co., Ltd.
  • Hetero Drugs Limited
  • Inbiopro Solutions Pvt. Ltd.
  • Innovent Biologics, Inc.
  • Johnson & Johnson
  • Kineta, Inc.
  • Mabion SA
  • Mabtech Limited
  • Momenta Pharmaceuticals, Inc.
  • Mycenax Biotech Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Oncobiologics, Inc.
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Sandoz International GmbH
  • Swedish Orphan Biovitrum AB

For more information visit http://www.researchandmarkets.com/research/x4p9xn/psoriatic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals